EuroEyes International Eye Clinic Management
Management criteria checks 4/4
EuroEyes International Eye Clinic's CEO is Jörn Jörgensen, appointed in Mar 2019, has a tenure of 5.67 years. total yearly compensation is HK$2.75M, comprised of 86.9% salary and 13.1% bonuses, including company stock and options. directly owns 54.9% of the company’s shares, worth HK$754.32M. The average tenure of the management team and the board of directors is 5.7 years and 5.7 years respectively.
Key information
Jörn Jörgensen
Chief executive officer
HK$2.7m
Total compensation
| CEO salary percentage | 86.9% |
| CEO tenure | 5.7yrs |
| CEO ownership | 54.9% |
| Management average tenure | 5.7yrs |
| Board average tenure | 5.7yrs |
Recent management updates
Recent updates
EuroEyes International Eye Clinic's (HKG:1846) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Sep 05
EuroEyes International Eye Clinic (HKG:1846) Is Reducing Its Dividend To HK$0.0489
Jun 09EuroEyes International Eye Clinic (HKG:1846) Is Paying Out Less In Dividends Than Last Year
May 09Earnings Tell The Story For EuroEyes International Eye Clinic Limited (HKG:1846) As Its Stock Soars 27%
May 06EuroEyes International Eye Clinic's (HKG:1846) Dividend Will Be Reduced To HK$0.0489
Apr 25EuroEyes International Eye Clinic's (HKG:1846) Dividend Will Be Reduced To HK$0.0489
Mar 31What Is EuroEyes International Eye Clinic Limited's (HKG:1846) Share Price Doing?
Nov 21Analysts Have Just Cut Their EuroEyes International Eye Clinic Limited (HKG:1846) Revenue Estimates By 15%
Sep 08EuroEyes International Eye Clinic Limited (HKG:1846) Shares Could Be 24% Below Their Intrinsic Value Estimate
Jul 31Analysts Just Made A Major Revision To Their EuroEyes International Eye Clinic Limited (HKG:1846) Revenue Forecasts
Apr 25There Are Reasons To Feel Uneasy About EuroEyes International Eye Clinic's (HKG:1846) Returns On Capital
Dec 05EuroEyes International Eye Clinic (HKG:1846) Will Pay A Larger Dividend Than Last Year At HK$0.099
May 26EuroEyes International Eye Clinic's (HKG:1846) Upcoming Dividend Will Be Larger Than Last Year's
May 12EuroEyes International Eye Clinic's (HKG:1846) Dividend Will Be Increased To HK$0.099
Apr 27EuroEyes International Eye Clinic (HKG:1846) Is Increasing Its Dividend To HK$0.099
Apr 08Slowing Rates Of Return At EuroEyes International Eye Clinic (HKG:1846) Leave Little Room For Excitement
Mar 07Is Now An Opportune Moment To Examine EuroEyes International Eye Clinic Limited (HKG:1846)?
Jan 18The Returns At EuroEyes International Eye Clinic (HKG:1846) Aren't Growing
Nov 02There Are Reasons To Feel Uneasy About EuroEyes International Eye Clinic's (HKG:1846) Returns On Capital
May 20CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | HK$108m |
| Mar 31 2024 | n/a | n/a | HK$120m |
| Dec 31 2023 | HK$3m | HK$2m | HK$131m |
| Sep 30 2023 | n/a | n/a | HK$121m |
| Jun 30 2023 | n/a | n/a | HK$110m |
| Mar 31 2023 | n/a | n/a | HK$100m |
| Dec 31 2022 | HK$3m | HK$2m | HK$89m |
| Sep 30 2022 | n/a | n/a | HK$102m |
| Jun 30 2022 | n/a | n/a | HK$115m |
| Mar 31 2022 | n/a | n/a | HK$124m |
| Dec 31 2021 | HK$3m | HK$3m | HK$134m |
| Sep 30 2021 | n/a | n/a | HK$123m |
| Jun 30 2021 | n/a | n/a | HK$113m |
| Mar 31 2021 | n/a | n/a | HK$89m |
| Dec 31 2020 | HK$360k | n/a | HK$66m |
| Sep 30 2020 | n/a | n/a | HK$38m |
| Jun 30 2020 | n/a | n/a | HK$10m |
| Mar 31 2020 | n/a | n/a | HK$5m |
| Dec 31 2019 | HK$272k | n/a | -HK$3m |
Compensation vs Market: Jörn's total compensation ($USD352.84K) is about average for companies of similar size in the Hong Kong market ($USD347.88K).
Compensation vs Earnings: Jörn's compensation has been consistent with company performance over the past year.
CEO
Jörn Jörgensen (69 yo)
5.7yrs
Tenure
HK$2,746,000
Compensation
Dr. Jörn Slot Jörgensen serves as Executive Chairman of the Board and Chief Executive Officer at EuroEyes International Eye Clinic Limited since March 25, 2019. He joined EuroEyes International Eye Clinic...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 5.7yrs | HK$2.75m | 54.9% HK$ 754.3m | |
| CFO & Executive Director | 5.7yrs | HK$1.64m | 0.086% HK$ 1.2m | |
| VP of Denmark & Executive Director | 5.7yrs | HK$360.00k | 1.91% HK$ 26.2m | |
| Executive Director | 2.3yrs | HK$6.85m | 0.74% HK$ 10.2m | |
| Senior Vice President of Medical Affairs (International) | 5.7yrs | no data | no data | |
| Senior Vice President of Operations (Germany) | 5.7yrs | no data | no data | |
| Senior Consultant of Operations | 5.7yrs | no data | no data | |
| Senior Vice President of Denmark | 5.7yrs | no data | no data | |
| Company Secretary | 4.6yrs | no data | no data |
5.7yrs
Average Tenure
61yo
Average Age
Experienced Management: 1846's management team is seasoned and experienced (5.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 6.3yrs | HK$2.75m | 54.9% HK$ 754.3m | |
| CFO & Executive Director | 5.9yrs | HK$1.64m | 0.086% HK$ 1.2m | |
| VP of Denmark & Executive Director | 5.7yrs | HK$360.00k | 1.91% HK$ 26.2m | |
| Executive Director | 2.3yrs | HK$6.85m | 0.74% HK$ 10.2m | |
| Non-Executive Director & Strategic Advisor | 5.7yrs | HK$360.00k | 0.083% HK$ 1.1m | |
| Independent Non-Executive Director | 5.7yrs | HK$360.00k | no data | |
| Independent Non-Executive Director | 3.6yrs | HK$360.00k | no data | |
| Independent Non Executive Director | 5.7yrs | HK$360.00k | no data |
5.7yrs
Average Tenure
60.5yo
Average Age
Experienced Board: 1846's board of directors are considered experienced (5.7 years average tenure).